Name
antihypertensive_n
Label
Antihypertensive: Number taken verified by inspection
Units
medications
Type
numeric
Tags
htn
Visit number vs Antihypertensive: Number taken verified by inspection
N Mean StdDev Median Min Max Unknown Total
Baseline 318 2.4 ± 1.4 2.0 0.0 7.0 - 318
Follow-up 300 2.4 ± 1.4 2.0 0.0 6.0 1 301
Treatment Arm vs Antihypertensive: Number taken verified by inspection
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 318 2.4 ± 1.4 2.0 0.0 7.0 - 318
Healthy Lifestyles and Sleep Education - control arm (HLSE) 106 2.3 ± 1.3 2.0 0.0 7.0 - 106
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 106 2.5 ± 1.3 2.0 0.0 6.0 - 106
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 106 2.3 ± 1.5 2.0 0.0 6.0 - 106
Treatment Arm vs Antihypertensive: Number taken verified by inspection
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 300 2.4 ± 1.4 2.0 0.0 6.0 1 301
Healthy Lifestyles and Sleep Education - control arm (HLSE) 100 2.3 ± 1.2 2.0 0.0 5.0 - 100
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 101 2.5 ± 1.4 2.0 0.0 6.0 - 101
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 99 2.3 ± 1.6 2.0 0.0 6.0 1 100
Age category vs Antihypertensive: Number taken verified by inspection
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 318 2.4 ± 1.4 2.0 0.0 7.0 - 318
45-54 years 53 2.0 ± 1.2 2.0 0.0 5.0 - 53
55-64 years 139 2.5 ± 1.5 2.0 0.0 7.0 - 139
65 years or older 126 2.4 ± 1.3 2.0 0.0 6.0 - 126
Age category vs Antihypertensive: Number taken verified by inspection
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 300 2.4 ± 1.4 2.0 0.0 6.0 - 300
45-54 years 49 2.0 ± 1.2 2.0 0.0 5.0 - 49
55-64 years 127 2.4 ± 1.5 2.0 0.0 6.0 - 127
65 years or older 124 2.5 ± 1.3 2.0 0.0 6.0 - 124
Gender of the participant vs Antihypertensive: Number taken verified by inspection
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 318 2.4 ± 1.4 2.0 0.0 7.0 - 318
Female 84 2.0 ± 1.2 2.0 0.0 5.0 - 84
Male 234 2.5 ± 1.4 2.0 0.0 7.0 - 234
Gender of the participant vs Antihypertensive: Number taken verified by inspection
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 300 2.4 ± 1.4 2.0 0.0 6.0 1 301
Female 79 2.0 ± 1.3 2.0 0.0 5.0 - 79
Male 221 2.5 ± 1.4 2.0 0.0 6.0 1 222
Race of the participant vs Antihypertensive: Number taken verified by inspection
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 317 2.4 ± 1.4 2.0 0.0 7.0 - 317
White 256 2.3 ± 1.4 2.0 0.0 7.0 - 256
American Indian or Alaskan Native 2 0.0 ± 0.0 0.0 0.0 0.0 - 2
Black or African American 43 2.7 ± 1.4 2.0 0.0 6.0 - 43
Asian 6 1.8 ± 0.8 2.0 1.0 3.0 - 6
Native Hawaiian or other Pacific islander 1 1.0 - 1.0 1.0 1.0 - 1
Other 4 1.8 ± 1.5 2.0 0.0 3.0 - 4
Multiple 5 2.8 ± 1.3 3.0 1.0 4.0 - 5
Race of the participant vs Antihypertensive: Number taken verified by inspection
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 299 2.4 ± 1.4 2.0 0.0 6.0 - 299
White 241 2.4 ± 1.4 2.0 0.0 6.0 - 241
American Indian or Alaskan Native 2 0.0 ± 0.0 0.0 0.0 0.0 - 2
Black or African American 41 2.6 ± 1.4 3.0 0.0 5.0 - 41
Asian 6 1.8 ± 0.8 2.0 1.0 3.0 - 6
Native Hawaiian or other Pacific islander 1 1.0 - 1.0 1.0 1.0 - 1
Other 3 2.7 ± 1.5 3.0 1.0 4.0 - 3
Multiple 5 2.4 ± 1.1 2.0 1.0 4.0 - 5